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Background
Hematuria, either macroscopic or microscopic, is an
incidental finding of multiple nephrologic or urologic
disorders. Disturbances of urine inhibitors or pro-
motors have been suggested as the potential causes
of isolated idiopathic hematuria in children and its
recurrence. Meanwhile, appropriate treatment of
these risk factors might improve secondary asymp-
tomatic or macroscopic hematuria.
Objectives
The aim of this study was to identify contribution of
urinary biochemical abnormalities in children with
isolated idiopathic hematuria.
Methods
About 522 children with isolated hematuria were
evaluated in a prospective cross-sectional study.
Data such as clinical manifestations, family history,
laboratory examinations, structural anomalies, and
urine biochemistry were obtained. Patients with
nephrolithiasis, nephrocalcinosis, tubulointerstitial
disorder, genitourinary abnormality, urinary tract
infection, and glomerular disorder were excluded
from the study. Variables such as calcium, citrate,
oxalate, phosphate, uric acid, cystine, and magne-
sium were measured in 24-h urine collection. In
addition, serum levels of electrolytes, urea, creati-
nine, parathyroid hormone, and bicarbonate were
identified.Variables No (%) <5 years old (%) Female
Hypocitraturia 60.7 70.9 (p < 0.001) 66.6 (p
Hypomagnesuria 58.2 64.9 (p Z 0.008) 71.1 (p
Hyperuricosuria 35.8 39.6 (p Z 0.12) 61.2 (p
Hypercalciuria 33.7 28.5 (p Z 0.2) 65.8 (p
Hyperoxaluria 24.9 27.1 (p Z 0.3) 70.8 (p
FH, familial history; NL, nephrolithiasis.
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Mean age at diagnosis was 5.9 years, and females
outnumbered males (2/1). Of those, 88.5% had
microscopic hematuria, and 12.6% experienced epi-
sodes of gross hematuria. Abdominal pain was the
most common clinical manifestations. Urinary tract
infection occurred in 30% of cases. Totally, 94% of
patients had single or multiple metabolic abnor-
malities in 24-h urine excretion including hypoci-
traturia, 60.7%; hypomagnesuria, 58.2%;
hyperuricosuria, 35.8%; hypercalciuria, 33.7%;
hyperoxaluria, 33.7%; and cystinuria, 0.76%,
respectively. About 8% of cases had mixed urine
metabolic disturbances. Most patients had mild he-
maturia (red blood cell <10/high power field (hpf)),
and 18% had significant hematuria (>30/hpf), with
no statistical correlation to urine metabolic abnor-
malities. About 80% of patients had a history of
nephrolithiasis in their relatives.Discussion
Decreased urinary inhibitor concentration followed
by increased stimulator concentration were the
most common abnormalities in patients with idio-
pathic hematuria. Accordingly, measurement of
urinary biochemical concentration is highly recom-
mended in children with isolated hematuria. In
addition, investigating the therapeutic effect of
potassium citrate supplements is highly recom-
mended in these patients to prevent future stone
formation and treatment of hematuria.(%) FH of NL (%) Gross hematuria (%)
Z 0.9) 80.1 (p Z 0.9) 11 (p Z 0.9)
Z 0.005) 81.3 (p Z 0.5) 10.5 (p Z 0.98)
Z 0.77) 84 (p Z 0.11) 10.2 (p Z 0.47)
Z 0.9) 83.6 (p Z 0.26) 10.4 (p Z 0.66)
Z 0.2) 78.5 (p Z 0.5) 11.5 (p Z 0.68)
Company.
Table 1 Characteristics of children with asymptomatic
hematuria.
Variables No (%) <5 years old (%) Female (%)
FH of stone 80.3 84.7 (p Z 0.02) 79.7 (p Z 0.98)
Abdominal
pain
74.5 71.4 (p Z 0.17) 78.8 (p Z 0.002)
Dysuria 40.6 41.4 (p Z 0.73) 49.5 (p < 0.001)
UTI 31 30.8 (p Z 0.94) 39.1 (p < 0.001)
Gross
hematuria
12.6 13.3 (p Z 0.25) 9.5 (p Z 0.05)
FH, familial history; UTI, urinary tract infection.
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Idiopathic hematuria is an important diagnostic and chal-
lenging dilemma in children. Asymptomatic hematuria is an
important manifestation of nephrologic or urologic disor-
ders with an incidence of 0.4e4.1%. Isolated idiopathic
hematuria is considered after exclusion of all pathophysi-
ologic mechanisms of hematuria, which needs multiple
diagnostic procedures for an accurate diagnosis [1].
Urinary biochemical abnormalities are considered the
potential reversible causes of asymptomatic idiopathic
hematuria in both children and adults [1,2].
An imbalance between urinary promotors (calcium,
urate, cystine, and oxalate) and inhibitors (phosphate,
magnesium, citrate, nephrocalcin, and glycosamino-
glycan) excretion has been suggested in the pathogenesis
of idiopathic hematuria rather than any single abnor-
mality [3,4].
In fact, hematuria of unknown origin might frequently
occur in patients with hypercalciuria and hyperoxaluria and
less commonly in patients with hyperuricosuria, which
could improve with specific treatment of the related ab-
normality [1].
The purpose of this study was to identify urinary
biochemical excretion rate in children with unexplained
isolated microscopic or macroscopic hematuria.
Materials and methods
This prospective cross-sectional cohort study was per-
formed in children younger than 5 years with idiopathic
hematuria, who are referred to the nephrology clinics be-
tween July 2011 and March 2017. It was approved by the
local ethics committee and performed in accordance with
the ethical standards as laid down in the 1964 Declaration
of Helsinki. Informed consent was obtained from legal
guardians of the involved patients.
Patients with definite causes of hematuria such as
nephrolithiasis, urinary tract infection, genitourinary ab-
normalities, glomerular or tubular disorders, renal insuffi-
ciency, abnormal blood gas analysis, severe obesity,
immobilization, and drug-induced abnormalities (cortico-
steroids, diuretics, and anticonvulsants) were excluded.
Clinical manifestations, laboratory findings, and radiologic
examinations were evaluated in all cases.
Twenty-fourehour urine collection was performed on a
usual diet for one or two times and analyzed for metabolic
risk factors including calcium, citrate, oxalate, phosphate,
uric acid, cystine, and magnesium levels. In addition, the
urine was collected in 2 separate containers with HCl for
the measurement of urine calcium content and without
additional substance. In addition, serum levels of sodium,
potassium, calcium, phosphorus, urea, creatinine, alkaline
phosphatase, parathyroid hormone, and blood gas values
were measured.
Serum and urine calcium were measured by ion-selective
electrode method. Serum and urine magnesium and phos-
phate were identified using an automated analyzer. Uric
acid was calculated by the uricase method. In addition,
serum and urine creatinine were measured by Jaffe kinetic
method.Urine citrate and oxalate were determined by the
enzymatic procedure. Urinary cystine excretion was docu-
mented by detection of hexagonal urinary cystine crystals
and discoloration of sodium nitroprusside.
Abnormal values for urine biochemicals were based on
published criteria in children with urolithiasis [5] including
hypercalciuria, urine calcium >4 mg/kg/day; hyper-
oxaluria, urine oxalate >0.5 mmol/1.73 m2 body surface
area (BSA)/day; hyperuricosuria, urine uric acid >815 mg/
1.73 m2 BSA/day; hypocitraturia, urine citrate <320 mg/
1.73 m2 BSA/day; and hypomagnesuria, urine magnesium
<88 mg/1.73 m2 BSA.
Continuous variables were expressed as
mean  standard deviation, and discrete variables were
identified as percentage. The c2 and Fisher’s exact tests
were used to identify significant difference between pro-
portional nominal data. Meanwhile, numerical data were
compared by the student’s t-test. A p value < 0.05 was
considered statistically significant.Results
A total of 681 patients with hematuria were evaluated in
this study. Of them, 159 cases were excluded for associated
nephrolithiasis or glomerular disorders.
About 88.5% of 522 enrolled patients had isolated
microscopic hematuria, and 11.5% presented with gross
hematuria at the beginning of presentation. Mean age at
the time of diagnosis was 5.9 years (range: 1e14.5), and
66% were females.
Occasional abdominal pain was the most common
symptom in 74.5% of patients. Most patients (80.3%) had a
history of nephrolithiasis in their relatives (Table 1).
Urine metabolic abnormalities were identified in 94% of
cases, with the predominance of hypocitraturia, followed
by hypomagnesuria, hyperuricosuria, hypercalciuria,
hyperoxaluria, and cystinuria (Table 2). Hypocitraturia,
hypercalciuria, hyperuricosuria, and hyperoxaluria were
identified in 68% (p < 0.001), 21% (p Z 0.002), 31%
(p Z 0.01), and 22% (p Z 0.11) of patients with hypo-
magnesuria, respectively. In addition, 20e68% of cases with
hypomagnesuria had associated increased calcium, uric
acid, and oxalate excretion, and hyperuricosuria was found
in 51.4% of patients with hypercalciuria (p < 0.001).
RBC count was <10/hpf in 42%, 10e30/hpf in 40%, and
>30/hpf in 18% of patients, which had no significant cor-
relation with urine metabolic abnormalities.
Table 2 Urinary biochemistry in children with asymptomatic hematuria.
Variables No (%) <5 years old (%) Female (%) FH of NL (%) Gross hematuria (%)
Hypocitraturia 60.7 70.9 (p < 0.001) 66.6 (p Z 0.9) 80.1 (p Z 0.9) 11 (p Z 0.9)
Hypomagnesuria 58.2 64.9 (p Z 0.008) 71.1 (p Z 0.005) 81.3 (p Z 0.5) 10.5 (p Z 0.98)
Hyperuricosuria 35.8 39.6 (p Z 0.12) 61.2 (p Z 0.77) 84 (p Z 0.11) 10.2 (p Z 0.47)
Hypercalciuria 33.7 28.5 (p Z 0.2) 65.8 (p Z 0.9) 83.6 (p Z 0.26) 10.4 (p Z 0.66)
Hyperoxaluria 24.9 27.1 (p Z 0.3) 70.8 (p Z 0.2) 78.5 (p Z 0.5) 11.5 (p Z 0.68)
FH, familial history; NL, nephrolithiasis.
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Urinary biochemical abnormalities are important causes of
asymptomatic idiopathic hematuria in pediatric patients
[1]. Microcrystallization with uroepithelial damage is the
essential mechanism of persistent isolated microscopic
hematuria or recurrent macroscopic hematuria in these
patients in the absence of nephrolithiasis [6].
Most of the study patients had microscopic hematuria vs
gross hematuria. In the study by Spivacow et al. [1] on 60
children with idiopathic hematuria and crystalluria, 88.3%
had gross hematuria, followed by microhematuria in 11.7%
and both types of hematuria in 5.1% of patients.
Screening of urine biochemical excretion has been sug-
gested in patients with recurrent abdominal or flank pain,
voiding dysfunction, urinary tract infection, osteopenia,
frequency-dysuria syndrome, genital bleeding, enuresis,
red urine, isolated persistent microscopic hematuria,
recurrent gross hematuria, hereditary hematuria, and fa-
milial history of nephrolithiasis [7,8]. Abdominal pain was
the most common symptom of crystalluria in the study
patients. However, none of the patients suffered from
abdominal or flank pain in the other reports.
About 80% of the study patients had a family history of
nephrolithiasis in their first or second degree relatives,
compared with 40e79% in the previous studies [1], which
could be related to the higher incidence of consanguinity in
the study parents.
Idiopathic hypercalciuria has been reported in children
with hematuria since 1980s and early 1990s, when renal
ultrasound was increasingly used [9]. It has been reported
in 30e43.5% of patients with isolated microscopic
hematuria and in 15.5e22.5% of those with gross hematuria
[1]. Similarly, about 30% of the study patients had idio-
pathic hypercalciuria after exclusion of all pathologic cau-
ses of increased urine calcium excretion.
Lowering urine calcium excretion by protein and salt
restriction, increased fluid intake, and thiazide and citrate
compounds have been recommended in patients with
persistent hypercalciuria, recurrent macroscopic hematu-
ria, or recurrent nephrolithiasis. However, hematuria might
recur after withdrawal of thiazide treatment [6,10,11].
Hyperuricosuria is defined as urinary uric acid excretion
of more than 95% of normal values, which accounts for
5e20% of recurrent hematuria in children. About 30% of the
study patients had increased urinary uric acid excretion
with normal serum uric acid level. Restriction of purine
intake and treatment with allopurinol decreased uric acid
level with resolution of hematuria over 6e12 months in the
study by Perrone et al. [12].Primary hyperoxaluria is highly suspected in children
with recurrent nephrolithiasis or unexplained hematuria
through a mechanism similar to hypercalciuria and hyper-
uricosuria [13]. In fact, unexplained hematuria was the
most common manifestation of patients with hyperoxaluria
in the study by Alimardini et al. [14] and found in 11.7% of
cases in the study by Spivacow [1]. Therapeutical ap-
proaches such as increased fluid intake and pyridoxine,
citrate, and magnesium preparations have been recom-
mended for treatment of hyperoxaluria and associated
hematuria [15]. About one-third of the study patients
had primary renal hyperoxaluria >0.5 mmol/1.73 m2/
d without nephrolithiasis, nephrocalcinosis, and severe
hyperoxaluria.
Clinical manifestations of cystinuria occur secondary to
stone formation and [5] and might improve with normali-
zation of urine cystine excretion [16]. Considering low
incidence of cystinuria, only 4 patients had cystine excre-
tion in the study, and none of them had associated neph-
rolithiasis. These findings indicate screening of cystinuria in
patients with isolated idiopathic hematuria without uro-
logic complications.
Hypocitraturia was the most frequent abnormality in
60% of the study patients and more common in children
younger than 5 years. Similarly, it was the most common
metabolic abnormality in 52% of pediatric kidney stone
formers in the study by Tefekli et al. [17] and accounted
the second most frequent metabolic disturbance in 31.7% of
children in the other report [1]. Urine citrate was signifi-
cantly lower in patients with nephrolithiasis than in the
healthy control group in the study by Batinic et al. [18] and
in one of the authors’ previous report [19].
Magnesium is an important inhibitor of crystallization
and stone formation in normal urine. More than 50% of the
study patients had hypomagnesuria with normal serum
magnesium level.
Up to this research, this is one of the largest cohort
studies of children with idiopathic hematuria. It was
showed that decreased urinary inhibitor concentration
followed by increased promoter excretion were the po-
tential reversible causes of idiopathic hematuria in chil-
dren. However, a lot of the study patients had both
etiologies simultaneously. Therefore, measurement of
urine biochemical excretion is highly recommended in pa-
tients with isolated idiopathic hematuria, unexplained
abdominal pain, recurrent urinary tract infection, dysuria,
and familial history of nephrolithiasis to prevent unnec-
essary invasive diagnostic procedures. As a limitation of this
study, it is highly suggested to investigate therapeutic ef-
fect of potassium citrate supplements for prevention of
165.e4 E. Valavi et al.future stone formation in children with idiopathic hema-
turia. In addition, it is suggested to perform this study in
different populations to identify the correlation between
cultural variables, urinary metabolic abnormality, and
idiopathic hematuria.Author statements
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